Trial · NCT01726816
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 16 of 16
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | A/C ratio | 16 week | The change in the A/C ratio from baseline to the end of treatment(16 week) \[Time Frame: baseline to 16 weeks\] |
| Secondary | Serum creatinine | 16 week | The change in the Serum creatinine from baseline to the end of treatment. |
| Secondary | eGFR | 16 week | The change in the eGFR from baseline to the end of treatment(16 week) |
| Secondary | cystatin C | 16 week | The change in the cystatin C from baseline to the end of treatment(16 week) |
| Secondary | urine albumin | 16 week | The change in the urine albumin from baseline to the end of treatment(16 week) |
| Secondary | P/C ratio | 16 week | The change in the P/C ratio from baseline to the end of treatment(16 week) |
| Other | Total Cholesterol | 16 week | The change in the Total cholesterol from baseline to the end of treatment(16 week) |
| Other | Triglyceride | 16 week | The change in the Triglyceride from baseline to the end of treatment(16 week) |
| Other | LDL-C | 16 week | The change in the LDL-C from baseline to the end of treatment(16 week) |
| Other | HDL-C | 16 week | The change in the HDL-C from baseline to the end of treatment(16 week) |
| Other | oxidized LDL | 16 week | The change in the oxidized LDL from baseline to the end of treatment(16 week) |
| Other | d-ROM | 16 week | The change in the d-ROM from baseline to the end of treatment(16 week) |
| Other | urinary fibronectin | 16 week | The change in the urinary fibronectin from baseline to the end of treatment(16 week) |
| Other | urinary transferrin | 16 week | The change in the urinary transferrin from baseline to the end of treatment(16 week) |
| Other | insulin | 16 week | The change in the insulin from baseline to the end of treatment(16 week) |
| Other | c-peptide | 16 week | The change in the c-peptide from baseline to the end of treatment(16 week) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01726816/registered